Taurine is a natural product of the exchange of sulfur-containing amino acids: cysteine, cysteamine, methionine. Taurine has osmoregulatory and membrane-protective properties, positively affects the phospholipid composition of cell membranes, normalizes the exchange of calcium and potassium ions in cells. In taurine, the properties of the inhibitory neurotransmitter are revealed, it possesses anti-stress action, it can regulate the release of gamma-aminobutyric acid (GABA), adrenaline, prolactin and other hormones, and regulate responses to them. By participating in the synthesis of respiratory chain proteins in mitochondria, taurine regulates oxidative processes and exhibits antioxidant properties; affects enzymes such as cytochromes, involved in the metabolism of various xenobics.
Taurine improves metabolic processes in the heart, liver and other organs and tissues.In chronic diffuse liver disease taurine increases blood flow and reduces the severity of cytolysis.
Treatment with CardioActiv®
Taurine in cardiovascular insufficiency (CVS) leads to a reduction in stagnant phenomena in small and large circles of the circulation: intracardiac diastolic pressure decreases, myocardial contractility increases (maximum rate of contraction and relaxation, indices of contractility and relaxation). The drug moderately reduces blood pressure (BP) in patients with hypertension and has virtually no effect on blood pressure in patients with cardiovascular failure with low blood pressure.
Cardio Active® Taurine reduces side effects that occur when an overdose of cardiac glycosides and blockers of "slow" calcium channels; reduces the hepatotoxicity of antifungal agents. Increases working capacity in severe physical exertion.
At a diabetes approximately in 2 weeks after the beginning of reception of a preparation Kardioaktiv® Taurine decreases the concentration of glucose in the blood. There was also a significant decrease in the concentration of triglycerides, to a lesser extent - the concentration of cholesterol, a decrease in the atherogenicity of plasma lipids.With prolonged use of the drug (about 6 months), improvement of the microcirculatory blood flow of the eye was noted. Taurine improves metabolic processes in the heart, liver and other organs and tissues.
In chronic diffuse liver disease taurine increases blood flow and reduces the severity of cytolysis.